Trial no.:
|
PACTR202105734020705 |
Date of Approval:
|
31/05/2021 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Intravenous Magnesium Sulphate Versus in Wetting solution in Counteracting Epinephrine Cardiac Adverse Events: Prospective Randomized controlled Trial. |
Official scientific title |
Intravenous Magnesium Sulphate Versus in Wetting solution in Counteracting Epinephrine Cardiac Adverse Events: Prospective Randomized controlled Trial. |
Brief summary describing the background
and objectives of the trial
|
This study will be conducted to evaluate the efficacy of intravenous versus wetting solution MgSO4 in counteracting epinephrine induced cardiac adverse events (e.g. tachyarrhythmia, and hypertension) as primary outcome, and its effect on pain scores and total analgesic requirement as secondary outcome. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
02/12/2020 |
Actual trial start date |
06/03/2021 |
Anticipated date of last follow up |
02/12/2021 |
Actual Last follow-up date |
06/03/2022 |
Anticipated target sample size (number of participants) |
129 |
Actual target sample size (number of participants) |
120 |
Recruitment status |
Completed |
Publication URL |
|
|